← Back to Search

Behavioural Intervention

TMS + Cognitive Behavioral Therapy for Suicide Risk

N/A
Recruiting
Led By Jennifer Marie Primack, PhD MA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month follow up
Awards & highlights

Study Summary

This trial will test whether combining two existing treatments, cognitive behavioral therapy and transcranial magnetic stimulation, can reduce suicide rates among veterans, which have remained unchanged for the past 10 years.

Who is the study for?
This trial is for Veterans who have recently attempted suicide or had the intent to, as confirmed by hospital records and assessments. It's not open to those with significant neurological disorders, bipolar disorder, severe cognitive impairment, metal implants incompatible with MRI, pregnancy/lactation plans during the study period, history of moderate/severe TBI, unstable medical conditions, seizure disorders or primary psychotic disorders.Check my eligibility
What is being tested?
The trial tests a combination of brief cognitive behavioral therapy (BCBT) and repetitive transcranial magnetic stimulation (TMS) in reducing Veteran suicides. These treatments are available at VA Medical Centers but haven't been used together before. The study aims to create an effective treatment protocol.See study design
What are the potential side effects?
Potential side effects from TMS may include discomfort at the stimulation site on the head, headache, lightheadedness or seizures in rare cases. BCBT generally does not cause side effects but discussing distressing topics can sometimes temporarily increase emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Columbia Suicide Severity Rating Scale (CSSRS)
Secondary outcome measures
Change in Beck Scale for Suicide Ideation (SSI)
Change in Treatment History Questionnaire
Change in World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: TMS + Brief Cognitive Behavioral TherapyActive Control2 Interventions
Combined transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide
Group II: Sham TMS + Brief cognitive behavioral therapyPlacebo Group2 Interventions
Sham Transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,610 Previous Clinical Trials
3,305,054 Total Patients Enrolled
39 Trials studying Suicide
6,416 Patients Enrolled for Suicide
Jennifer Marie Primack, PhD MAPrincipal InvestigatorProvidence VA Medical Center, Providence, RI
1 Previous Clinical Trials
107 Total Patients Enrolled
1 Trials studying Suicide
107 Patients Enrolled for Suicide

Media Library

Brief Cognitive Behavioral Therapy (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03952468 — N/A
Suicide Research Study Groups: Sham TMS + Brief cognitive behavioral therapy, TMS + Brief Cognitive Behavioral Therapy
Suicide Clinical Trial 2023: Brief Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT03952468 — N/A
Brief Cognitive Behavioral Therapy (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03952468 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people have volunteered to participate in this clinical trial thus far?

"Yes, the information available on clinicaltrials.gov indicates that this trial is still looking for patients to enroll. This particular study was posted on November 4th, 2019 and updated February 4th, 2020. They are hoping to enroll a total of 130 patients from 1 location."

Answered by AI
Recent research and studies
~0 spots leftby Apr 2024